A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS MODELS IN TYPE 1 DIABETES MELLITUS

被引：0
|
作者：
Henriksson, M. [1 ]
Jindal, R. [2 ]
Sternhufvud, C. [3 ]
Sorstadius, E. [3 ]
Bergenheim, K. [3 ]
Willis, M. [4 ]
机构：
[1] Linkoping Univ, Linkoping, Sweden
[2] Paraxei Int, Chandigarh, India
[3] AstraZeneca, Molndal, Sweden
[4] Swedish Inst Hlth Econ, Lund, Sweden
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2097
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB58
引用
收藏
页码：A607 / A607
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness Of Drug Compliance In Type 2 Diabetes Mellitus Patients
    Maciel, Olga
    Vera, Zully
    Marin, Gustavo H.
    Morinigo, Macarena
    Maidana, Mabel
    Mastroianni, Patricia
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2018, 9 (05): : 1824 - 1829
  • [42] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ARGENTINA
    Rodriguez, L.
    Lew, D.
    VALUE IN HEALTH, 2020, 23 : S115 - S115
  • [43] Cost-effectiveness of Preventing Type-2-Diabetes mellitus in Germany
    Schaufler, T. M.
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2009, 14 (02): : 71 - 75
  • [44] Cost-effectiveness of metabolic surgery in type 2 diabetes mellitus and obesity
    Thiem, Helena
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2023, 28 (04): : 149 - 150
  • [45] COST-EFFECTIVENESS OF DAPAGLIFLOZIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN PERU
    Elgart, J. F.
    Gonzalez, L.
    Prestes, M.
    Manrique, H.
    Solorzano, J.
    Gagliardino, J. J.
    VALUE IN HEALTH, 2016, 19 (03) : A203 - A203
  • [46] Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review
    Jiejin Zhu
    Ying Zhou
    Gang Wang
    Diabetes Therapy, 2024, 15 : 61 - 76
  • [47] Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review
    Zhu, Jiejin
    Zhou, Ying
    Wang, Gang
    DIABETES THERAPY, 2024, 15 (01) : 215 - 227
  • [48] COST-EFFECTIVENESS MODELLING OF TYPE-1 DIABETES
    Thokala, P.
    VALUE IN HEALTH, 2012, 15 (07) : A664 - A664
  • [49] COST-EFFECTIVENESS MODELLING OF TYPE-1 DIABETES
    Thokala, P.
    Kruger, J.
    Brennan, A.
    VALUE IN HEALTH, 2012, 15 (04) : A181 - A182
  • [50] The cost-effectiveness of intensive therapy for diabetes mellitus
    Herman, WH
    Dasbach, EJ
    Songer, TJ
    Eastman, RC
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1997, 26 (03) : 679 - +
12345